“…Inasmuch as it is unlikely that each of the pathologies presented in TABLES 2 and 3 represents a separate cause of schizophrenia, a major question is how many of these individual brains demonstrate significant deviations from the norm in more 69 Not found 70 Abnormal orientation of neurons 71 Not found 70,72 Decreased MAP 2, 5, in hippocampal subfields 73 Decreased synaptophysin mRNA 74 Decreased Glu R1 Glu R2 75 Entorhinal cortex: Abnormal architecture in 40% of cases 76,77 Not found 78 Thalamus: Decreased neurons in mediodorsal nucleus 79,80 Prefrontal and cingulate cortex: Upregulation of GABA A receptor binding 81,82 Decreased small neuron density 83 Increased neuron density 84 No change 88 Increased vertical axons cingulate cortex 86 Decreased GAD gene expression 85 Abnormal migration of NADPH cells 87,88 Association cortex: Increased GAP- 43 89 Gliosis: Periventricular, periaqueductal, subcortical 4,90,91 No glial increase in cortex, brain stem, thalamus, limbic structures 51,91,92 None in "purified" sample 53 Fibrin degradation products increased: possible marker for inflammation 93 than one domain. Unfortunately, few laboratories can conduct more than one or two assays in the same areas of the same brains.…”